- Home
- PMCB vs JDZG Comparison
PMCB vs JDZG Comparison
Compare PMCB & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- JDZG
- Stock Information
- Founded
- PMCB 1996
- JDZG 2020
- Country
- PMCB United States
- JDZG China
- Employees
- PMCB N/A
- JDZG N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- JDZG Other Consumer Services
- Sector
- PMCB Health Care
- JDZG Real Estate
- Exchange
- PMCB Nasdaq
- JDZG Nasdaq
- Market Cap
- PMCB 7.3M
- JDZG 7.2M
- IPO Year
- PMCB N/A
- JDZG 2024
- Fundamental
- Price
- PMCB $1.11
- JDZG $2.45
- Analyst Decision
- PMCB
- JDZG
- Analyst Count
- PMCB 0
- JDZG 0
- Target Price
- PMCB N/A
- JDZG N/A
- AVG Volume (30 Days)
- PMCB 12.0K
- JDZG 107.4K
- Earning Date
- PMCB 08-12-2025
- JDZG 07-15-2025
- Dividend Yield
- PMCB N/A
- JDZG N/A
- EPS Growth
- PMCB N/A
- JDZG N/A
- EPS
- PMCB 1.29
- JDZG 0.25
- Revenue
- PMCB N/A
- JDZG $2,567,741.00
- Revenue This Year
- PMCB N/A
- JDZG N/A
- Revenue Next Year
- PMCB N/A
- JDZG N/A
- P/E Ratio
- PMCB $0.86
- JDZG $9.97
- Revenue Growth
- PMCB N/A
- JDZG 20.36
- 52 Week Low
- PMCB $1.00
- JDZG $1.61
- 52 Week High
- PMCB $2.42
- JDZG $21.28
- Technical
- Relative Strength Index (RSI)
- PMCB 54.71
- JDZG N/A
- Support Level
- PMCB $1.00
- JDZG N/A
- Resistance Level
- PMCB $1.07
- JDZG N/A
- Average True Range (ATR)
- PMCB 0.05
- JDZG 0.00
- MACD
- PMCB 0.01
- JDZG 0.00
- Stochastic Oscillator
- PMCB 73.33
- JDZG 0.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.